Literature DB >> 18250179

Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania.

Lasse S Vestergaard1, John P Lusingu, Morten A Nielsen, Bruno P Mmbando, Daniel Dodoo, Bartholomew D Akanmori, Michael Alifrangis, Ib C Bygbjerg, Martha M Lemnge, Trine Staalsoe, Lars Hviid, Thor G Theander.   

Abstract

Plasmodium falciparum variant surface antigens (VSA) are involved in the pathogenesis of malaria. Immunoglobulin G (IgG) with specificity for VSA (anti-VSA IgG) is therefore considered important for acquired immunity. To better understand the nature and dynamics of variant-specific IgG responses at population level, we conducted an immunoepidemiological study in nearby communities in northeastern Tanzania, situated at different altitudes and therefore exposed to different levels of P. falciparum transmission intensity. Samples of plasma and infected red blood cells (IRBC) were collected from 759 individuals aged 0 to 19 years. Plasma levels of IgG with specificity for VSA expressed by a panel of different parasite isolates were measured by flow cytometry, while the ability of plasma to inhibit IRBC adhesion to CD36 was examined in cellular assays. The level and repertoire of the heterologous anti-VSA IgG response developed dramatically in individuals at 1 to 2 years of age in the high-transmission area, reaching a maximum level at around 10 years of age; only a modest further increase was observed among older children and adults. In contrast, at lower levels of malaria transmission, anti-VSA IgG levels were lower and the repertoire was more narrow, and similar age- and transmission-dependent differences were observed with regard to the ability of the plasma samples to inhibit adhesion of IRBC to CD36. These differences indicate a strong and dynamic relationship between malaria exposure and functional characteristics of the variant-specific antibody response, which is likely to be important for protection against malaria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250179      PMCID: PMC2423063          DOI: 10.1128/IAI.01401-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity.

Authors:  Morten A Nielsen; Trine Staalsoe; Jørgen A L Kurtzhals; Bamenla Q Goka; Daniel Dodoo; Michael Alifrangis; Thor G Theander; Bartholomew D Akanmori; Lars Hviid
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 2.  The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria.

Authors:  Peter C Bull; Kevin Marsh
Journal:  Trends Microbiol       Date:  2002-02       Impact factor: 17.079

3.  The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission.

Authors:  H A Giha; S Rosthoj; D Dodoo; L Hviid; G M Satti; T Scheike; D E Arnot; T G Theander
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.184

4.  Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

Authors:  G Snounou; X Zhu; N Siripoon; W Jarra; S Thaithong; K N Brown; S Viriyakosol
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 Jul-Aug       Impact factor: 2.184

Review 5.  Antigenic variation at the infected red cell surface in malaria.

Authors:  S Kyes; P Horrocks; C Newbold
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

6.  Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age.

Authors:  P C Bull; M Kortok; O Kai; F Ndungu; A Ross; B S Lowe; C I Newbold; K Marsh
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

7.  Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children.

Authors:  D Dodoo; T Staalsoe; H Giha; J A Kurtzhals; B D Akanmori; K Koram; S Dunyo; F K Nkrumah; L Hviid; T G Theander
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 8.  Malaria in 2002.

Authors:  Brian Greenwood; Theonest Mutabingwa
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

Review 9.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

10.  Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania.

Authors:  John P A Lusingu; Lasse S Vestergaard; Bruno P Mmbando; Chris J Drakeley; Caroline Jones; Juma Akida; Zacharia X Savaeli; Andrew Y Kitua; Martha M Lemnge; Thor G Theander
Journal:  Malar J       Date:  2004-07-28       Impact factor: 2.979

View more
  19 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites.

Authors:  Paulina Ampomah; Liz Stevenson; Michael F Ofori; Lea Barfod; Lars Hviid
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

3.  How selection forces dictate the variant surface antigens used by malaria parasites.

Authors:  Maite Severins; Don Klinkenberg; Hans Heesterbeek
Journal:  J R Soc Interface       Date:  2011-07-06       Impact factor: 4.118

4.  Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.

Authors:  Alfredo Mayor; Eduard Rovira-Vallbona; Sonia Machevo; Quique Bassat; Ruth Aguilar; Llorenç Quintó; Alfons Jiménez; Betuel Sigauque; Carlota Dobaño; Sanjeev Kumar; Bijender Singh; Puneet Gupta; Virander S Chauhan; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

5.  Nutrient Deficiencies and Potential Alteration in Plasma Levels of Naturally Acquired Malaria-Specific Antibody Responses in Tanzanian Children.

Authors:  Erasto V Mbugi; Gerco den Hartog; Jacobien Veenemans; Jaffu O Chilongola; Hans Verhoef; Huub F J Savelkoul
Journal:  Front Nutr       Date:  2022-06-17

6.  Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.

Authors:  Enmoore Lin; Benson Kiniboro; Laurie Gray; Stuart Dobbie; Leanne Robinson; Annemarie Laumaea; Sonja Schöpflin; Danielle Stanisic; Inoni Betuela; Melinda Blood-Zikursh; Peter Siba; Ingrid Felger; Louis Schofield; Peter Zimmerman; Ivo Mueller
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

7.  The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.

Authors:  Inès Vigan-Womas; Adjimon Lokossou; Micheline Guillotte; Alexandre Juillerat; Graham Bentley; André Garcia; Odile Mercereau-Puijalon; Florence Migot-Nabias
Journal:  Malar J       Date:  2010-10-05       Impact factor: 2.979

8.  Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.

Authors:  Joseph J Campo; Carlota Dobaño; Jahit Sacarlal; Caterina Guinovart; Alfredo Mayor; Evelina Angov; Sheetij Dutta; Chetan Chitnis; Eusebio Macete; John J Aponte; Pedro L Alonso
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

9.  Effects of age, hemoglobin type and parasite strain on IgG recognition of Plasmodium falciparum-infected erythrocytes in Malian children.

Authors:  Amir E Zeituni; Kazutoyo Miura; Mahamadou Diakite; Saibou Doumbia; Samuel E Moretz; Ababacar Diouf; Gregory Tullo; Tatiana M Lopera-Mesa; Cameron D Bess; Neida K Mita-Mendoza; Jennifer M Anderson; Rick M Fairhurst; Carole A Long
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.

Authors:  Alain Nahum; Annette Erhart; Daniel Ahounou; Désiré Bonou; Chantal Van Overmeir; Joris Menten; Martin Akogbeto; Marc Coosemans; Achille Massougbodji; Umberto D'Alessandro
Journal:  Malar J       Date:  2009-03-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.